Baxter to sell its BioPharma Solutions Business to Advent International and Warburg Pincus for US $4.25billion

Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation

RPG Life Sciences posts Q4 revenue at Rs 118.49 Cr

Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23

DG, ICMR and Director CSIR-NIScPR release special issues of Vigyan Pragati & Science Reporter magazines

Science communication brings behavioural changes

SK Capital completes acquisition of Apotex

Healthcare Global Enterprises revenue up 19%

Technology and innovation play a pivotal role towards enhancing healthcare systems, increasing access to healthcare services, and reducing costs of therapies and consultations

Apollo Genomics Institutes launched at Apollo Hospitals Navi Mumbai

Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders

ProBioGen collaborates with Boehringer Ingelheim on DirectedLuck transposase technology

The new project further expands the partner's long-term collaboration on new technologies for R&D

Themis Medicare launches Lenzetto for treatment of menopausal symptoms

It ensures sufficient serum estradiol levels to alleviate menopausal symptoms

Harbor Healthcare advises a California long-term care pharmacy on its sale & strategic partnership

The strategic acquirer maintains a nationwide presence in the LTC pharmacy space

Glenmark launches Triple FDC of Teneligliptin with Pioglitazone and Metformin for adults with Type 2 Diabetes

This FDC has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained release (SR) formulation